Finance

Beta
Ask
Lists
WHWK:NASDAQ
Whitehawk Therapeutics Inc
$4.16
+2.46%
(+0.100) 1D
Jun 12, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WHWK...
Open
$4.06
High
$4.34
Low
$4.06
Mkt. cap
223.74M
Avg. vol.
408.38K
Volume
161.37K
52-wk high
$5.50
52-wk low
$1.57
EPS
-$3.59
Beta
0.77
Shares outstanding
49.45M
No. of employees
29
Open
$4.06
High
$4.34
Low
$4.06
Mkt. cap
223.74M
Avg. vol.
408.38K
Volume
161.37K
52-wk high
$5.50
52-wk low
$1.57
EPS
-$3.59
Beta
0.77
Shares outstanding
49.45M
No. of employees
29
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to WHWK in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for WHWK in the last 3 months.
Highest
Current $4.16
$8.00 (+92.31%)
Average
$7.33 (+76.20%)
Lowest
$7.00 (+68.27%)
News stories
From sources across the web
About Whitehawk Therapeutics Inc
CEO-
Employees29
Founded2007
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
48.81M
14.34M
19.02M
17.23M
Cost of revenue
48.81M
14.34M
19.02M
17.23M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.94M
5.20M
5.87M
6.29M
Operating expense
5.94M
5.20M
5.87M
6.29M
Total operating expenses
54.75M
19.55M
24.89M
23.52M
Operating income
-54.75M
-19.55M
-24.89M
-23.52M
Other non operating income
158.00K
127.00K
17.00K
-
EBT including unusual items
-52.62M
-17.75M
-23.25M
-22.19M
EBT excluding unusual items
-52.62M
-17.57M
-23.25M
-22.19M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-52.62M
-17.75M
-23.25M
-22.19M
Net profit margin
-
-
-
-
Earnings per share
-0.76
-0.25
-0.34
-0.32
Interest and investment income
1.98M
1.85M
1.61M
1.33M
Interest expense
-
-
-
-
Net interest expenses
1.98M
1.85M
1.61M
1.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
-54.73M
-19.54M
-24.89M
-23.52M
Gain or loss from assets sale
-
177.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more